ACADIA Pharmaceuticals, Inc. (ACAD)
29.12
-0.61
(-2.05%)
USD |
NASDAQ |
Aug 28, 16:00
29.12
0.00 (0.00%)
After-Hours: 19:38
ACADIA Pharmaceuticals Free Cash Flow : 145.62M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 145.62M |
| March 31, 2026 | 113.59M |
| December 31, 2025 | 6.308M |
| September 30, 2025 | 98.97M |
| June 30, 2025 | 88.25M |
| March 31, 2025 | 49.60M |
| December 31, 2024 | 157.20M |
| September 30, 2024 | 202.66M |
| June 30, 2024 | 80.48M |
| March 31, 2024 | 23.66M |
| December 31, 2023 | -23.35M |
| September 30, 2023 | -132.59M |
| June 30, 2023 | -74.31M |
| March 31, 2023 | -55.64M |
| December 31, 2022 | -114.04M |
| September 30, 2022 | -113.30M |
| June 30, 2022 | -129.64M |
| March 31, 2022 | -141.89M |
| December 31, 2021 | -126.78M |
| September 30, 2021 | -133.15M |
| June 30, 2021 | -140.60M |
| March 31, 2021 | -155.04M |
| December 31, 2020 | -143.75M |
| September 30, 2020 | -144.18M |
| June 30, 2020 | -138.60M |
| Date | Value |
|---|---|
| March 31, 2020 | -137.20M |
| December 31, 2019 | -152.26M |
| September 30, 2019 | -161.99M |
| June 30, 2019 | -186.36M |
| March 31, 2019 | -188.93M |
| December 31, 2018 | -169.62M |
| September 30, 2018 | -159.87M |
| June 30, 2018 | -175.03M |
| March 31, 2018 | -193.21M |
| December 31, 2017 | -218.57M |
| September 30, 2017 | -252.10M |
| June 30, 2017 | -243.38M |
| March 31, 2017 | -239.54M |
| December 31, 2016 | -209.91M |
| September 30, 2016 | -181.12M |
| June 30, 2016 | -163.42M |
| March 31, 2016 | -138.65M |
| December 31, 2015 | -123.56M |
| September 30, 2015 | -106.82M |
| June 30, 2015 | -92.34M |
| March 31, 2015 | -78.76M |
| December 31, 2014 | -66.61M |
| September 30, 2014 | -59.11M |
| June 30, 2014 | -51.45M |
| March 31, 2014 | -39.37M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Incyte Corp. | 1.890B |
| Agios Pharmaceuticals, Inc. | -365.25M |
| Biogen, Inc. | 2.49B |
| Insmed, Inc. | -837.67M |
| Vertex Pharmaceuticals, Inc. | 3.796B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 100.78M |
| Cash from Investing (Quarterly) | -8.529M |
| Cash from Financing (Quarterly) | 10.49M |
| Free Cash Flow Per Share (Quarterly) | 0.5536 |
| Free Cash Flow to Equity (Quarterly) | 72.63M |
| Free Cash Flow to Firm (Quarterly) | 95.69M |
| Free Cash Flow Yield | 2.91% |